Delivery Order SPE2DB20D2104-SPE2DB24FV74F

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,599,158 units of the PRIORIX vaccine. The contract has an award date of August 27, 2024, an ultimate completion date of August 28, 2024, and a ceiling value of $17,564.40. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,159.60, is for the delivery of PRIORIX vaccine vials. The contract has an ultimate completion date of December 17, 2024 and a firm fixed price pricing type. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,913.60 firm fixed-price delivery order is for the PRIORIX vaccine product. The contract has an ultimate completion date of August 23, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $60,565.20, is for the delivery of PRIORIX VIALS, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 23, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of PRIORIX VIALS, a pharmaceutical product. The firm fixed-price contract has a ceiling value of $1,521.93 and a completion date of September 16, 2024. This order was placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.42, is for the delivery of PRIORIX vials, a vaccine product. It is a firm fixed-price delivery order contract type, with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PRIORIX Vials, a vaccine product. The contract has a ceiling value of $5,047.10 and a period of performance through April 23, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,721.28, is for the supply of PRIORIX VIALS, a medical product. It is a firm fixed-price contract with a completion date of November 15, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PRIORIX Vials. The $8,621.54 firm-fixed-price contract has an ultimate completion date of August 15, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, through December 2025, for delivering a comprehensive range of medical commodities to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PRIORIX VIALS. The $11,510.43 firm-fixed-price delivery order has an ultimate completion date of February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV74F
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,480 units of the PRIORIX vaccine. The firm-fixed-price contract has a ceiling value of $4,733.67 and a completion date of August 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of the DLA's efforts to procure essential medical commodities, including vaccines, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:35 AM